Haloperidol D4
Cat. No.：YN1730070
CAS No. ：1189986-59-1
| 产品名称: | Haloperidol D4 |
| CAS No.: | 1189986-59-1 |
| Chemical Name: | 4-(4-(4-chlorophenyl-2,3,5,6-d4)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one |
| Synonyms: | 氟哌啶醇D4 |
| 分子量: | 379.89 |
| 分子式: | C₂₁H₁₉D₄ClFNO₂ |
| SMILES: | ClC1=C([2H])C([2H])=C(C2(O)CCN(CCCC(C3=CC=C(F)C=C3)=O)CC2)C([2H])=C1[2H] |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Haloperidol D4 是 haloperidol 的氘代物。Haloperidol 为dopamine D2 receptor的拮抗剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Burstein, E.S., Ma, J., Wong, S., et al.Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: Identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonistJ. Pharmacol. Exp. Ther.315(3),1278-1287(2005)
Richelson, E., and Souder, T.Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compoundsLife Sci.68(1),29-39(2000)
Creese, I., Burt, D.R., and Snyder, S.H.Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugsJ. Neuropsychiatry Clin. Neurosci.8(2),223-226(1996)
Swerdlow, N.R., and Geyer, M.A.Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophreniaPharmacol. Biochem. Behav.44(3),741-744(1993)
